NL8104832A - Nieuwe beta-galactosidase-remmer. - Google Patents

Nieuwe beta-galactosidase-remmer. Download PDF

Info

Publication number
NL8104832A
NL8104832A NL8104832A NL8104832A NL8104832A NL 8104832 A NL8104832 A NL 8104832A NL 8104832 A NL8104832 A NL 8104832A NL 8104832 A NL8104832 A NL 8104832A NL 8104832 A NL8104832 A NL 8104832A
Authority
NL
Netherlands
Prior art keywords
galactosidase
activity
pharmaceutically acceptable
enzyme
methanol
Prior art date
Application number
NL8104832A
Other languages
English (en)
Dutch (nl)
Original Assignee
Shionogi & Co
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Shionogi & Co filed Critical Shionogi & Co
Publication of NL8104832A publication Critical patent/NL8104832A/nl

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12Q—MEASURING OR TESTING PROCESSES INVOLVING ENZYMES, NUCLEIC ACIDS OR MICROORGANISMS; COMPOSITIONS OR TEST PAPERS THEREFOR; PROCESSES OF PREPARING SUCH COMPOSITIONS; CONDITION-RESPONSIVE CONTROL IN MICROBIOLOGICAL OR ENZYMOLOGICAL PROCESSES
    • C12Q1/00—Measuring or testing processes involving enzymes, nucleic acids or microorganisms; Compositions therefor; Processes of preparing such compositions
    • C12Q1/54—Measuring or testing processes involving enzymes, nucleic acids or microorganisms; Compositions therefor; Processes of preparing such compositions involving glucose or galactose
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P35/00—Antineoplastic agents
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • C07K14/195—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from bacteria
    • C07K14/36—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from bacteria from Actinomyces; from Streptomyces (G)
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N1/00—Microorganisms; Compositions thereof; Processes of propagating, maintaining or preserving microorganisms or compositions thereof; Processes of preparing or isolating a composition containing a microorganism; Culture media therefor
    • C12N1/20—Bacteria; Culture media therefor
    • C12N1/205—Bacterial isolates
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N9/00—Enzymes; Proenzymes; Compositions thereof; Processes for preparing, activating, inhibiting, separating or purifying enzymes
    • C12N9/14—Hydrolases (3)
    • C12N9/24—Hydrolases (3) acting on glycosyl compounds (3.2)
    • C12N9/2402—Hydrolases (3) acting on glycosyl compounds (3.2) hydrolysing O- and S- glycosyl compounds (3.2.1)
    • C12N9/2468—Hydrolases (3) acting on glycosyl compounds (3.2) hydrolysing O- and S- glycosyl compounds (3.2.1) acting on beta-galactose-glycoside bonds, e.g. carrageenases (3.2.1.83; 3.2.1.157); beta-agarase (3.2.1.81)
    • C12N9/2471—Beta-galactosidase (3.2.1.23), i.e. exo-(1-->4)-beta-D-galactanase
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12P—FERMENTATION OR ENZYME-USING PROCESSES TO SYNTHESISE A DESIRED CHEMICAL COMPOUND OR COMPOSITION OR TO SEPARATE OPTICAL ISOMERS FROM A RACEMIC MIXTURE
    • C12P1/00—Preparation of compounds or compositions, not provided for in groups C12P3/00 - C12P39/00, by using microorganisms or enzymes
    • C12P1/06—Preparation of compounds or compositions, not provided for in groups C12P3/00 - C12P39/00, by using microorganisms or enzymes by using actinomycetales
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12Y—ENZYMES
    • C12Y302/00—Hydrolases acting on glycosyl compounds, i.e. glycosylases (3.2)
    • C12Y302/01—Glycosidases, i.e. enzymes hydrolysing O- and S-glycosyl compounds (3.2.1)
    • C12Y302/01023—Beta-galactosidase (3.2.1.23), i.e. exo-(1-->4)-beta-D-galactanase
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12R—INDEXING SCHEME ASSOCIATED WITH SUBCLASSES C12C - C12Q, RELATING TO MICROORGANISMS
    • C12R2001/00—Microorganisms ; Processes using microorganisms
    • C12R2001/01—Bacteria or Actinomycetales ; using bacteria or Actinomycetales
    • C12R2001/465—Streptomyces

Landscapes

  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Health & Medical Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • Zoology (AREA)
  • Wood Science & Technology (AREA)
  • Genetics & Genomics (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • General Health & Medical Sciences (AREA)
  • Biochemistry (AREA)
  • General Engineering & Computer Science (AREA)
  • Biotechnology (AREA)
  • Microbiology (AREA)
  • Medicinal Chemistry (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Molecular Biology (AREA)
  • Biomedical Technology (AREA)
  • Biophysics (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Analytical Chemistry (AREA)
  • Mycology (AREA)
  • Physics & Mathematics (AREA)
  • Virology (AREA)
  • Tropical Medicine & Parasitology (AREA)
  • Emergency Medicine (AREA)
  • Gastroenterology & Hepatology (AREA)
  • Immunology (AREA)
  • Animal Behavior & Ethology (AREA)
  • Veterinary Medicine (AREA)
  • Public Health (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Preparation Of Compounds By Using Micro-Organisms (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Medicines Containing Material From Animals Or Micro-Organisms (AREA)
  • Compounds Of Unknown Constitution (AREA)
NL8104832A 1980-10-27 1981-10-26 Nieuwe beta-galactosidase-remmer. NL8104832A (nl)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
JP55150927A JPS5774090A (en) 1980-10-27 1980-10-27 Novel beta-galactosidase inhibitor, gt-2558, its derivative, and production
JP15092780 1980-10-27

Publications (1)

Publication Number Publication Date
NL8104832A true NL8104832A (nl) 1982-05-17

Family

ID=15507444

Family Applications (1)

Application Number Title Priority Date Filing Date
NL8104832A NL8104832A (nl) 1980-10-27 1981-10-26 Nieuwe beta-galactosidase-remmer.

Country Status (7)

Country Link
US (1) US4497797A (,)
JP (1) JPS5774090A (,)
DE (1) DE3142400A1 (,)
FR (1) FR2492664A1 (,)
GB (1) GB2086394B (,)
NL (1) NL8104832A (,)
NZ (1) NZ198680A (,)

Families Citing this family (7)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
WO1987006265A1 (fr) * 1986-04-17 1987-10-22 Kyowa Hakko Kogyo Co., Ltd. Nouveaux composes dc-88a et dc-89a1, et procede pour leur preparation
EP0313846B1 (en) * 1987-10-29 1994-05-04 American Cyanamid Company Method for controlling chronic respiratory disease, and necrotic enteritis in avian species
US5179023A (en) * 1989-03-24 1993-01-12 Research Corporation Technologies, Inc. Recombinant α-galactosidase a therapy for Fabry disease
WO1996012492A1 (en) * 1994-10-25 1996-05-02 Merck & Co., Inc. Microbial synthesis of hiv protease inhibitors
US6210666B1 (en) 1997-10-21 2001-04-03 Orphan Medical, Inc. Truncated α-galactosidase A to treat fabry disease
DK2675902T3 (da) 2011-02-17 2019-06-03 Univ Pennsylvania Sammensætninger og fremgangsmåder til at ændre vævsspecificitet og forbedre aav9-medieret genoverførsel
WO2015121488A1 (en) * 2014-02-17 2015-08-20 Glaxosmithkline Intellectual Property Development Limited Microbiological process

Family Cites Families (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US3160560A (en) * 1957-08-23 1964-12-08 Upjohn Co Streptolydigin and production thereof
JPS5134916B2 (,) * 1974-03-06 1976-09-29
US3991183A (en) * 1975-05-01 1976-11-09 Pfizer Inc. Antibiotic produced by a species of micromonospora

Also Published As

Publication number Publication date
JPS5774090A (en) 1982-05-10
GB2086394B (en) 1984-03-07
FR2492664A1 (fr) 1982-04-30
GB2086394A (en) 1982-05-12
DE3142400A1 (de) 1982-11-25
US4497797A (en) 1985-02-05
FR2492664B1 (,) 1985-04-19
NZ198680A (en) 1985-04-30

Similar Documents

Publication Publication Date Title
US4254256A (en) Amino sugar compound
US4460765A (en) Enzyme inhibitor produced by cultivation of streptomyces microorganisms
SE468482B (sv) Framstaellning av monakolin k
EP0182315A2 (en) Novel antibiotic NK84-0218 pharmaceutical compositions containing it and process for the production of the same
CA1153966A (en) Physiologically active substance, ebelactone and production thereof
NL8104832A (nl) Nieuwe beta-galactosidase-remmer.
AU7677600A (en) Process for the preparation of mycophenolic acid and derivatives thereof
EP0019302A1 (de) Neue tetracyclische Verbindungen, Verfahren zu deren Herstellung, deren Verwendung und pharmazeutische Präparate
DE2109854B2 (de) 7beta-(D-5-Amino-5-carboxy valeramido)-3-(carbamoyloxymethyl>7-methoxy-3-cephem-4-carbonsäure und deren Salze, Verfahren zu ihrer Herstellung und solche Verbindungen enthaltende Arzneimittel
CH618606A5 (,)
EP0317292B1 (en) New antibiotics of the mureidomycin group, their preparation, and their therapeutic use
US5039663A (en) Antibiotics called "mureidomycins A, B, C, and D" and their therapeutic use
US4197292A (en) Novel amylase inhibitors
US4011140A (en) Process for producing antitumor compound
US3974035A (en) Process for preparing a cephamycin type antibiotic substance
JPS5823077B2 (ja) 抗生物質ａｍ−３６０３およびその製造方法
US4803074A (en) FR-900848 substance and preparation thereof
US3825660A (en) Antibiotic no.156 and process for producing the same
US4992570A (en) UCN-1028A and UCN-1028C and process for the production thereof
US5213974A (en) Fermentation process for preparing antibiotics mureidomycins A, B, C and D
JPH0578322A (ja) 新規抗生物質ｓｆ２７３８物質及びその製造法並びに制癌剤
US4242327A (en) Antibiotic SF-2052 substance and production and use thereof
US3857756A (en) Process for production of antibiotic
DE69300658T2 (de) Anthracyclin Analogon, Verbindung UCEG.
JPS60116655A (ja) 新規なγ−フルオロ−Ｌ−トレオニンおよびその製造法

Legal Events

Date Code Title Description
A85 Still pending on 85-01-01
BV The patent application has lapsed